◆ 会议时间：2024年3月28-30日
◆ 会议地点：韩国 首尔

◆ 会议简介：

2024年韩国血液学会国际会议/第65届年会(ICKSH2024)将于2024年3月28-30日在韩国首尔举行，会议由韩国血液学会(KSH)主办，预计有来自40多个国家的1300多名与会者参会。大会科学计划包括如良性血液疾病，各种类型的血液系统恶性肿瘤，凝血/血栓形成相关疾病以及输血医学等主题。

韩国血液学会(KSH)成立于1958年，其宗旨是宣促进血液和造血及相关生理和病理现象的研究，现拥有约1500名成员，包括医师、科学家、护士和药剂师等。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)

ICKSH 2024
Korean Society of Hematology (KSH) International Conference & 65th Annual Meeting
Date: March 28-30, 2024
Venue: Seoul, Korea

摘要征集：

• Deadline for Abstract Submission: December 29, 2023
• Notification of Abstract Acceptance: January 19, 2024

点此提交摘要>>>Submit Abstract>>>

Abstract Submission Topics

• Acute Lymphoblastic Leukemia
• Lymphoma
• Acute Myeloid Leukemia
• Multiple Myeloma
• Myelodysplastic Syndrome
• Platelet/Hemostasis
• Anemia and Other Red Cell Disorders
• Cellular Therapy
• Bone Marrow Failure Syndromes
• Hematopoiesis/Stem Cell Biology
• Chronic Myeloid Leukemia
• Hematopoietic Stem Cell Transplantation
• Myeloproliferative Neoplasm
• Laboratory Hematology
• Histiocytosis and Other Dendritic Cell Neoplasm
• Quality of Life
• Transfusion Medicine
• Others

Welcome Message

On behalf of the organizing committee, it is our great pleasure to invite you to participate in the 2024 Korean Society of Hematology (KSH) International Conference & 65th Annual Meeting, hosted by KSH, from March 28 to 30, 2024.

Held every year since 2018, the ICKSH congress shares up-to-date information and provides a unique opportunity for world class leaders in the field to debate vital and contentious issues in Hematology.

Our programs will include topics such as benign hematologic diseases, various types of hematologic malignancies, coagulation/thrombosis related disorders and transfusion medicine through plenary lectures, as well as scientific and educational sessions.

In addition, a variety of stimulating social programs has been planned so participants can enjoy the fascinating Korean culture and share our warm spirit of friendship.

We welcome your support and look forward to seeing you at ICKSH 2024 in Seoul, Korea!

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。